C1 Esterase Inhibitor (Recombinant)
| Brand name | Ruconest |
|---|---|
| Active ingredient | C1 Esterase Inhibitor (Recombinant) |
| Strength | 2100IU |
| Dosage form | For Injection |
| Route | Intravenous |
| Modality | Biologic |
| FDA approval | July 2014 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.